MiMedx Group, Inc.MDXGNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 79% recommend buying.

Consensus Rating

Buy

14 analysts·Moderate coverage

79%

Rating Distribution

Strong Buy

00%

Buy

1179%

Hold

17%

Sell

214%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 130% higher.

Bear Case

$8.00

+57%

Consensus

$11.75

+130%

Bull Case

$16.00

+213%

Price Range14 analysts

Low

Consensus

High

$8.00

$16.00

Current Target

Current Price

$5.11

Upside to Target

$6.64

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$0.21(2 analysts)

P/E19x

Current: 18.5x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+20.37%

EPS+47.62%

FY2028

Rev+30.78%

EPS+196.71%

FY2029

Rev+13.77%

EPS—

Earnings Surprises

Beat rate:58%(7/12 quarters)

Avg surprise:+28.2%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Nov 15, 2024Mizuho Securities

MiMedx Group (MDXG) PT Raised to $16 at Mizuho

Target:$16.00

+76.1%from $9.09

Jul 2, 2024Cantor Fitzgerald

MiMedx initiated with an Overweight at Cantor Fitzgerald

Target:$11.00

+64.2%from $6.70

Apr 29, 2024Lake Street

Proposed new LCDs likely benefit MiMedx if implemented, says Lake Street

Target:$12.00

+91.5%from $6.26

Sep 7, 2022H.C. Wainwright

HC Wainwright & Co. Maintains Buy on MiMedx Group, Lowers Price Target to $8

Target:$8.00

+133.9%from $3.42

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance